We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

It’s Melanoma — Here’s What to Do Next

MedXY Editorial Team•Aug 13, 2025•news
health tipsmelanomaskin cancer

Understanding Melanoma

Come summer, beach days, pool swims, and all things outdoors call your name. But it’s essential to be careful about time in the sun. Sun exposure is a major contributor to skin cancer, the most common form of cancer in the United States. Among the different types of skin cancer, melanoma is responsible for a large majority of skin cancer deaths.

Melanoma can develop from existing moles or appear as new spots on the skin. The sooner melanoma is detected, the more treatment options are available—meaning early detection is crucial. Regular screenings and vigilance regarding changes in your skin can make a significant difference.

For more valuable melanoma tips and information, read on.

5 Common Signs of Melanoma

Doctors often use the ABCDE acronym to help identify melanoma’s warning signs. Each letter represents a specific symptom or characteristic to watch for:

  • A – Asymmetry: One half of a mole differs from the other in shape or size.
  • B – Borders: The edges of a mole are irregular—ragged or blurred—rather than clearly defined.
  • C – Color: Instead of being one uniform color, the mole has uneven shades or contains several colors, such as black, brown, tan, white, red, or blue.
  • D – Diameter: The mole is larger than 6 millimeters (about the size of a pencil eraser).
  • E – Evolving: The mole changes in size, shape, color, or elevation or has new symptoms, such as itching, bleeding, oozing, and crusting.

A Personal Experience: Leah Adams’ Journey

Leah Adams discovered an unusual mole on her chest and decided to visit her doctor. “I had my first-ever skin check,” Leah recalls. “Sure enough, the only mole they removed was the one on my chest.” A biopsy revealed a stage IA (early stage) malignant melanoma tumor.

Shortly after Leah’s diagnosis, her doctor informed her about the DecisionDx®-Melanoma test. “He recommended it,” Leah explains, “because the test can let you know, based on your tumor biology, whether you’re at low or high risk for your cancer spreading or coming back.” Leah agreed to take the test and learned she was low risk, easing her concerns about the potential progression of her disease.

Though waiting for the feedback from the test “was scary,” Leah acknowledges it helped her take steps forward after her diagnosis. “The test can give you next steps in your own education and awareness. Cancer opens your eyes, wakes you up, so if you have access to information that helps you live a better life, take it.”

The Importance of Regular Skin Checks

Regular skin checks are essential in the early detection of melanoma and can play a life-saving role. It’s recommended that individuals, especially those with risk factors (like a family history of skin cancer or atypical moles), should schedule annual skin examinations with a dermatologist. A professional evaluation can identify suspicious changes that may not be apparent at home.

Moreover, awareness of family history and other risk factors, such as excessive sun exposure and the use of tanning beds, should inform your skin health practices. Protective measures like sunscreen, protective clothing, and limiting sun exposure during peak hours can significantly reduce the risk of developing melanoma.

Conclusion

In summary, melanoma is a serious type of skin cancer that requires vigilance and proactive measures. Understanding the signs, undergoing regular screenings, and leveraging available tests for personalized risk assessments can empower individuals to take charge of their health. If you notice any changes in your skin or moles, don’t hesitate to consult a healthcare professional. Taking early action is your best defense against melanoma.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Impact of Neighborhood Socioeconomic Deprivation on Breslow Thickness and Clinical Outcomes in Head and Neck Cutaneous Melanoma: A Comprehensive ReviewThis review synthesizes evidence linking neighborhood socioeconomic deprivation with increased Breslow thickness and delayed surgical management in head and neck cutaneous melanoma, highlighting potential mechanisms and clinical implicationAug 24, 2026Neoadjuvant Intralesional Daromun Significantly Improves Outcomes in Resectable Stage III Melanoma: Insights from the PIVOTAL Phase III Trial UpdateUpdated PIVOTAL Phase III trial data demonstrate that neoadjuvant intralesional Daromun significantly improves recurrence-free and distant metastasis-free survival in resectable stage III melanoma without new safety concerns at 36.8 monthsAug 13, 2026Exploring Institutional and Insurance-Linked Disparities in Melanoma Outcomes: Insights from a VA and Tertiary Care Cohort StudyThis cohort study reveals differential melanoma survival outcomes linked to institutional settings and insurance types, highlighting the need for standardized care in advanced melanoma stages.Jul 14, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Immune Checkpoint Inhibitor-Associated Uveitis: Comparative Risk Across Cancers and Drug ClassesA multicenter study found that immune checkpoint inhibitor–associated uveitis risk varies by cancer type and drug class, with melanoma showing the highest intrinsic risk and RCC risk largely linked to ipilimumab/nivolumab exposure.Jun 4, 2026
Breaking the Wall: Can Intermittent Chemotherapy Overcome Primary Checkpoint Inhibitor Resistance in Metastatic Melanoma?The multicentre phase II PROMIT trial demonstrates that intermittent dacarbazine can sensitize BRAF wildtype metastatic melanoma patients with primary ICI resistance to subsequent ICI rechallenge, yielding an 18% objective response rate andMar 5, 2026
KEYVIBE-010: Why Adding TIGIT Inhibition to Pembrolizumab Failed to Benefit High-Risk Resected Melanoma PatientsThe Phase 3 KEYVIBE-010 trial demonstrates that adding vibostolimab to pembrolizumab in the adjuvant setting for melanoma does not improve outcomes, instead yielding a higher recurrence rate and increased toxicity, reinforcing pembrolizumabMar 2, 2026